These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26237809)

  • 41. Combination of channel-TURP and ILC versus standard TURP or ILC for elderly with benign prostatic hyperplasia: a randomized prospective trial.
    Zhang B; Wu G; Chen C; Song B; Li X; Zhong L; Wang H
    Urol Int; 2011; 87(4):392-9. PubMed ID: 21967798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial.
    Abt D; Mordasini L; Hechelhammer L; Kessler TM; Schmid HP; Engeler DS
    BMC Urol; 2014 Nov; 14():94. PubMed ID: 25425136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR; Agrawal CS
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia].
    Xu Y; Sun DC; Yang Y; Wei ZT; Hong BF; Zhang X
    Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):119-22. PubMed ID: 23711003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.
    Bozdar HR; Memon SR; Paryani JP
    J Ayub Med Coll Abbottabad; 2010; 22(4):194-6. PubMed ID: 22455296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of transurethral resection of prostate on quality of life in aged patients with benign prostatic hyperplasia].
    Cheng NZ; Tang ZY; Liu Y; Liu XS; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):975-8. PubMed ID: 19001744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial Canadian Experience of Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: Midterm Outcomes.
    Patel NR; Elterman DS; Thulasidasan N; Altman R; Tai E; Zener R; Stella SF; Annamalai G; Mafeld S; Simons ME
    Can Assoc Radiol J; 2021 Nov; 72(4):876-882. PubMed ID: 32673069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost Analysis of Prostate Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) in the Treatment of Benign Prostatic Hyperplasia.
    Bagla S; Smirniotopoulos J; Orlando J; Piechowiak R
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1694-1697. PubMed ID: 28560549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
    van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
    Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [X-ray-guided endovascular surgery in patients with benign prostatic hyperplasia and prostate cancer].
    Neimark AI; Tachalov MA; Neimark BA; Torbik DV; Arzamastsev DD
    Urologiia; 2017 Apr; (1):54-60. PubMed ID: 28394524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The risk and effectiveness of transurethral resection of prostate.
    Lertakyamanee J; Ruksamanee EO; Tantiwong A; Boonsuk K; Nilpradab I; Vorakijpokatorn P; Soontrapa S
    J Med Assoc Thai; 2002 Dec; 85(12):1288-95. PubMed ID: 12678166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
    Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
    BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: A prospective single-center investigation.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H; Wang Z
    Int J Urol; 2015 Aug; 22(8):766-72. PubMed ID: 25950927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients.
    Carnevale FC; Antunes AA; da Motta Leal Filho JM; de Oliveira Cerri LM; Baroni RH; Marcelino AS; Freire GC; Moreira AM; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):355-61. PubMed ID: 19908092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine.
    Kehinde EO; Abul F
    Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
    O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
    J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical observation of bipolar transurethral plasma kinetic resection of prostate for high risk benign prostate hyperplasia].
    Liu DY; Gu J; Zhang CY; Wang J; Tang Q; Zhou YF; Zhou WL; Wang MW; Zhu Y; Zhao JP
    Zhonghua Wai Ke Za Zhi; 2009 Apr; 47(7):545-7. PubMed ID: 19595217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Some aspects of transurethral resection of large benign prostatic hyperplasia].
    Managadze LG; Khvadagiani GG; Abdushelishvili KO; Managadze GL; Berulava DT
    Georgian Med News; 2007 Feb; (143):53-7. PubMed ID: 17404441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.